RESI Conference 2019 - Boston | Life Science Nation, LLC | 11 September 2019 | The Westin Copley Place, Boston, 10 Huntington Ave, Boston, MA 02116, USA

The Redefining Early Stage Investments (RESI) conference series was created by Life Science Nation (LSN) to bring together startups with early-stage investors and strategic channel partners. The goal was to maximize the capability of these companies, from seed to series B, to find partners who are a fit for their technology and stage of development. What‘s unique about RESI is that the event is cross border and cross domain, connecting startups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health, the “4 Ds”. RESI caters to both the earliest stage startups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding.

2019 Speakers

Shiv Krishnan
Sr. Director, Head, Partnering, External Sciences & Innovation, Global BioTherapeutics, Sanofi

Joyce Chan
Director, Business Development, Amgen

Murali Gopalakrishnan
Sr. Director, Head Search & Evaluation Neuroscience, AbbVie

Somjeet Dey
Senior Manager, Otsuka Pharmaceuticals

Chuck Stetson
CEO, Stetson Family Office

Christian Soschner
CEO, CS Life Science Invest

Paul Bertsch
Current Chief Scientist, Life Sciences Queensland

Dar-Bin Shieh
Deputy Minister, Ministry of Science and Technology (MoST)

Val Kratzman
Senior Advisor, Business FinlandDeanna Belsky, Associate, Dolby Family Ventures

Loretta McCarthy
Managing Partner, Golden Seeds

Richard Anders
Managing Director, Mass Medical Angels

Yaniv Sneor
Founding Member, Mid Atlantic Bio Angels

Shyam Patel
Assoc. Director, Portfolio Development & Review, California Institute for Regenerative Medicine

David Xu
Chief Business Officer, Viva Biotech

Hannah Shen
Associate Director, BridgeBio

Jane Hollingsworth
Managing Partner, Militia Hill Ventures

Peter Young
Venture Partner, Pappas Capital

Alejandro Zamorano
VP of Business Development, PainQx

Matthew Miller
Managing Director, Techstars + UnitedHealthcare

Robert Garber
Partner, 7wire Ventures

Valerie Photos
Managing Partner, Iaso Ventures

Sunil Shah
CEO, o2h Ventures

Barbara Schilberg
CEO, BioAdvance

Chris Church
Manager, Partnering & Strategy, AstraZeneca

Preston Noon
Principal, Agent Capital

Stephen Goodman
Founding Member, Mid Atlantic Bio Angels

James Kasuboski
Senior Director, Boehringer Ingelheim Venture Fund

Alicia Irurzen-Lafitte
Partner, UCB Ventures

Hakan Goker
Senior Investment Director, M Ventures

Olga Danilchanka
Senior Associate, MRL Ventures Fund

Shaoyu Chang
Vice President, FC Capital

Andy Li
Founding Partner, BioSense Global

Mark Tang
Managing Director, Good Health Capital

Weiyong Sun
Senior Director, Specialty Medicine Search & Evaluation, Daiichi Sankyo

Zishan Haroon
Chairman and General Partner, Julz Co LLC

Spencer Nam
Managing Director, Kensington-SV (KSV) Global Innovations

Jung-Hee Lim
Head of Investment, Biotech Investment Team, InterVest

Sung Soo Oh
Managing Director, Solidus Investment

Jae An, VP
Investment Division, Partners Investment Co., Ltd

Wendy Pan
Partner, Health Ventures, Sidley Austin LLP

Kimberly Nearing
Managing Director, Head of Life Sciences, Cedrus Group

Larry Cai
Executive Director, Business Development, Fosun Pharma

Laura Hong
President, KLUS Pharma

Rohit Pratap Singh
Vice President, Investments, Xeraya Capital

Michael Thomas
Director, Inova Strategic Investments

Elona Baum
Managing Director, DEFTA Partners

Gyan Kapur
Vice President, Activate Venture Partners

Sohaib Siddiqui
Director, Emerging Healthcare Technologies, Kettlebeck Developments

Uma Makhija
Associate Director, Business Development, Otsuka Pharmaceuticals

Bryan Grulke
Partner, Volcano Capital

Ibraheem Badejo
Sr. Director, New Ventures, Johnson & Johnson Innovation

Matthew Cohen
Director of Technology, Pangaea Ventures

Ronald Dorenbos
Head, Innovation Management & Scouting, Takeda Pharmaceuticals

Shahram Hezaji
Partner, BioAdvance

Sherry Grisewood
Chief Investment Officer, FoxHill Asset Management

Babette Güldenpfennig
Global Head of Licensing, Roche Diagnostics

David Cruikshank
Partner, ARCH Venture Partners

Regina Leung
Partner, Innovari Partners

Yizhen Dong
Principal, 11.2 Capital

Armen Vidian
Operating Partner, Data Collective

Pavan Choksi
Associate, Arkitekt Ventures

Rafael Torgovicky
Partner, Accelmed Growth Partners

Sean Cheng
Senior Associate, Philips Health Technology Ventures

Patrik Frei
Founder & CEO, Venture Valuation AG, Switzerland

Roger Kuan
Partner, McDermott Will & Emery

Al Sokol
Partner, McDermott Will & Emery

Rick Jones
Partner, BioAdvance

George Syrmalis
CEO, The iQ Group Global

Hemmie Chang
Partner, Foley Hoag LLP

Nilay Thaker
Associate, ARCH Venture Partners

Sundeep Lal
CEO and Founder, BioConnexUS

Yao Li Ho
Senior Director of Business Development, LYFE Capital

Chris Hanson
Partner, Grant Park Ventures

Phil Grayeski
Venture Associate, KdT Ventures

Renee Selman
Member, Robin Hood Ventures

Stephen Nagler
Executive Director, MedPro Investors

Carola Schropp
Managing Director, HAYIM Group

Jim Iversen
CEO & COO, Sen-Jam Pharmaceutical

Nancy Briefs
Co-Founder, President & CEO, AltrixBio

Thomas Forest Farb-Horch
CEO, President & Co-Founder, Thrive Bioscience

John MacMahon
CEO, Mitre Medical Corp.

Dennis Ford
Founder & CEO, Creator of RESI Conference Series, Life Science Nation

Greg Mannix
VP of International Business Development, Life Science Nation

Molly Minnear
Principal, Economic and Valuation Services, KPMG LLP

Nick Hemmerly
Director, Healthcare Investment Banking, PricewaterhouseCoopers Corporate Finance

Fang Shen
Assoc. Scientific Director, Immunology Discovery, Janssen R&D

Karina Sotnik
Director, University City Science Center

Lauren Swartz
Sr. Director, Department of Commerce, City of Philadelphia

Michael Poisel
Director, PCI Ventures, Penn Center for Innovation

Louis Kassa
Chief Operating Officer, Pennsylvania Biotechnology Center

Seamus Jiang
Managing Director, PwC US Deals Practices

Cynthia Cai
Senior Advisor, Norther Light Venture Capital

Echo Yang
Founder and CEO, MSQ Ventures

Evan Jones
Managing Member, jVen Capital

Frank Luo
Managing Director, Efung Capital

Ruhong Jiang
CEO, Applied StemCell. Inc

Aston Liu
Senior Director, GlaxoSmithKline

Kevin Heyeck
Venture Partner, 6 Dimensions Capital

Vladimir Walko
Board Member, Hatch Biofund Management

Xi-Yong Fu
President, Luye Bostone R&D LLC

David Ling
Partner and Head of China Center, KPMG LLP

Deping Chai
Patent Attorney, Moran, Lewis & Bockius LLP, Philadelphia, PA

Rui Fan
Principal, KPMG LLP

Samuel Chueh
Director, Department of Commerce,City of Philadelphia

2019 Sponsors, Partners and Exhibitors

TITLE SPONSORS:
• Stetson Family Office
• Life Science Nation

GOLD SPONSORS:
• McDermott
• MedMarc
• Boston Innovation Capital

MEDIA PARTNERS:
• FreeMind
• Big4Bio
• Bio Partner
• Keiretsu
• AZBio
• BusinessFrance
• Development of Center for Biotechnology
• Global Bio & Investment
• Life Science Invest
• New England-Israel Business Council
• Medi-Vantage
• China:SF
• UCSF Innovation Ventures
• Ontario Bioscience Innovation Organization

EXHIBITORS:
• Sino-American Pharmaceutical Professionals Association
• KOTRA
• Development Center for Biotechnology
• Business Sweden
• BusStim LLC
• Boulder Medical Device Accelerator
• BioInc@NYMC
• Entrepreneurs University
• LifeX
• Princeton University
• Venture Valuation
• Life Science Nation
• McDermott Will & Emery
• Shareworks by Morgan Stanley
• Medmarc
• Capital Advisors Group, Inc.
• Atheln
• Digital Health Recruitment (DHR)
• Triple Ring Technologies
• PCI
• BioHealth Innovation, Inc.
• PainQx
• Pact & Partners
• STC Biologics, Inc.